1. Ekhtiari H, Behzadi A, Oghabian M, Edalati H, Mokri A. Evaluation of visual cues inducing drug craving in intravenous heroin users. Adv Cogn Sci 2006;8(3):43-51. [
Google Scholar]
2. Alam Mehrjerdi Z, Mokri A, Ekhtiari H. Human Laboratory Settings for Assessing Drug Craving Implications for the Evaluation of Treatment Efficacy. Basic and Clinical Neuroscience 2011;2(3):5-11. [
Address]
3. Martel MO, Dolman AJ, Edwards RR, Jamison RN, Wasan AD. The association between negative affect and prescription opioid misuse in patients with chronic pain: the mediating role of opioid craving. J Pain. 2014;15(1):90-100. [
DOI:10.1016/j.jpain.2013.09.014] [
PMID] [
PMCID]
4. Witkiewitz K, Bowen S, Douglas H, Hsu SH. Mindfulness-based relapse prevention for substance craving. Addict Behav 2013;38(2):1563-71. [
DOI:10.1016/j.addbeh.2012.04.001] [
PMID] [
PMCID]
5. Franken IH, Kroon LY, Wiers RW, Jansen A. Selective cognitive processing of drug cues in heroin dependence. J Psychopharmacol. 2000;14(4):395-400. [
DOI:10.1177/026988110001400408] [
PMID]
6. Tiffany ST, Wray J. The continuing conundrum of craving. 2009. [
PubMed]
7. Thimm JC. Personality and early maladaptive schemas: A five-factor model perspective. J Behav Ther Exp Psychiatry.2010;41(4):373-80. [
DOI:10.1016/j.jbtep.2010.03.009] [
PMID]
8. Malinowski P. Neural mechanisms of attentional control in mindfulness meditation. Front Neurosci. 2013;7:8. [
DOI:10.3389/fnins.2013.00008] [
PMID] [
PMCID]
9. Ma SH, Teasdale JD. Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J Consult Clin Psychol 2004;72(1):31. [
DOI:10.1037/0022-006X.72.1.31] [
PMID]
10. Khanzadeh M, Edrisi F, Muhammadkhani S, Saidian M. Factor structure and psychometric properties of Emotional Schema Scale. J Clin Psychol 2013;3(11):91-119.
11. Baer RA, Smith GT, Hopkins J, Krietemeyer J, Toney L. Using self-report assessment methods to explore facets of mindfulness. Assessment 2006;13(1):27-45. [
DOI:10.1177/1073191105283504] [
PMID]
12. Somoza E, Baker S, Himmler C, LoCastro J, Mezinskis J, Simon S, et al. The Brief Substance Craving Scale-measuring craving in clinical trials. NIDA Res Monogr 1999;180:304-7.
13. Franken IH, Hendriks VM, Van den Brink W. Initial validation of two opiate craving questionnaires: the Obsessive Compulsive Drug Use Scale and the Desires for Drug Questionnaire. Addict Behav 2002;27(5):675-85. [
DOI:10.1016/S0306-4603(01)00201-5]
14. Besharat M, Ranjbar NF, Rostami R. a comparative study of family function of patients with substance use disorders of opioid and families normaL Individuals. 2008. [
Google Scholar]
15. Mokri A, Ekhtiari H, Edalati H, Ganjgahi H, Naderi P. Relationship between craving intensity and risky behaviors and impulsivity factors in different groups of opiate addicts. Iran J Psychiatry Clin Psychol 2008;14(3):258-68. [
Google Scholar]
16. Mokri A, Ekhtiari H, Edalati H, Ganjgahi H. Relationship between degree of craving and different dimensions of addiction severity in heroin intravenous users. Iran J Psychiatry Clin Psychol 2008;14(3):298-306. [
Google Scholar]
17. Bowen S, Chawla N, Collins SE, Witkiewitz K, Hsu S, Grow J, et al. Mindfulness-based relapse prevention for substance use disorders: A pilot efficacy trial. Subst Abus 2009;30(4):295-305. [
DOI:10.1080/08897070903250084] [
PMID] [
PMCID]
18. Kinchla MS. Mindfulness and sustained recovery from alcoholism: Massachusetts School of Professional Psychology; 2009. [
Proquest]
19. Bowen S. Effects of mindfulness-based instructions on negative affect, urges and smoking: University of Washington; 2008. [
Proquest]